COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 509: Articles 5081-5090  | Next

Optimizing COVID-19 testing strategies on college campuses: evaluation of the health and economic costs
Johnson, K. E., Pasco, R., Woody, S., Lachmann, M., Johnson-Leon, M., Bhavnani, D., Klima, J., Paltiel, A. D., Fox, S., Meyers, L. A.
10.1101/2022.12.04.22283074 — Posted: 2022-12-05
Risk of Type 1 Diabetes in Children is Not Increased after SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark
Noorzae, R., Junker, T. G., Hviid, A. P., Wohlfahrt, J., Olsen, S. F.
10.1101/2022.12.05.22283089 — Posted: 2022-12-05
Antibody Affinity Maturation to SARS-CoV-2 Omicron Variants in a Teachers Cohort
James-Pemberton, P. H., Kohli, S., Westlake, A., Antill, A., Olkhov, R., Shaw, A.
10.1101/2022.12.01.22282932 — Posted: 2022-12-05
SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent manner
Fonseca, D. L. M., Filgueiras, I. S., Marques, A. H., Vojdani, E., Halpert, G., Ostrinski, Y., Baiocchi, G. C., Placa, D. R., Freire, P. P., Pour, S. Z., Moll, G., Catar, R., Lavi, Y. B., Silverberg, J. I., Zimmerman, J., Miranda, G. C. d., Carvalho, R. F., Khan, T. A., Heidecke, H., Dalmolin, R. J., Luchessi, A. D., Ochs, H. D., Schimke, L. F., Amital, H., Riemekasten, G., Zyskind, I., Rosenberg, A. Z., Vojdani, A., Shoenfeld, Y., Cabral-Marques, O.
10.1101/2022.12.04.22282902 — Posted: 2022-12-05
Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa
Hussey, H., Vreede, H., Davies, M.-A., Heekes, A., Kalk, E., Hardie, D. R., Van Zyl, G., Naidoo, M., Morden, E., Bam, J.-L., Zinyakatira, N., Centner, C., Maritz, J., Opie, J., Chapanduka, Z., Mahomed, H., Smith, M., Cois, A., Pienaar, D., Redd, A., Preiser, W., Wilkinson, R. J., Chetty, K., Boulle, A., Hsiao, N.-y. M.
10.1101/2022.12.01.22282927 — Posted: 2022-12-05
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during pre- and omicron-dominant wave, from January 2021 through November 2022, Thailand: Longitudinal study
Suntronwong, N., Vichaiwattana, P., Klinfueng, S., Puenpa, J., Kanokudom, S., Assawakosri, S., Chansaenroj, J., Srimuan, D., Thatsanatorn, T., Songtaisarana, S., Sudhinaraset, N., Wanlapakorn, N., Poovorawan, Y.
10.1101/2022.12.01.22283006 — Posted: 2022-12-05
Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
Nasrallah, G., Ali, F., Younes, S., AlKhatib, H., Althani, A., YASSINE, H. M.
10.1101/2022.12.04.22283067 — Posted: 2022-12-05
Low Dimensional Chaotic Attractors in Daily Hospital Occupancy from COVID-19 in the USA and Canada
Goncalves, C. P. d. S.
10.1101/2022.12.04.22283069 — Posted: 2022-12-05
Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
Kadhem Al-Hakeim, H., Tahseen Al-Rubaye, H., S. Jubran, A., Almulla, A. F., Moustafa, S., Maes, M.
10.1101/2022.12.01.22283011 — Posted: 2022-12-04
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database
The OpenSAFELY Collaborative, , Zheng, B., Campbell, J., Carr, E. J., Tazare, J., Nab, L., Mahalingasivam, V., Mehrkar, A., Santhakumaran, S., Steenkamp, R., Loud, F., Lyon, S., Scanlon, M., Hulme, W. J., Green, A. C., Curtis, H. J., Fisher, L., Parker, E., Goldacre, B., Douglas, I., Evans, S., MacKenna, B., Bell, S., Tomlinson, L., Nitsch, D., The LH&W NCS (or CONVALESCENCE) Collaborative
10.1101/2022.12.02.22283049 — Posted: 2022-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).